Skip to main content
Prospective evaluation of an ultrathin strut biodegradable polymer-coated sirolimus-eluting stent: 12 months’ results from the S-FLEX UK registry
Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial
A prospective multicentre randomised all-comers trial to assess the safety and effectiveness of the thin-strut sirolimus-eluting coronary stent SUPRAFLEX: rationale & design of the Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimus
Clinical outcomes in 995 unselected real-world patients treated with an ultrathin biodegradable polymer-coated sirolimus-eluting stent: 12-month results from the FLEX Registry
Preliminary evaluation of clinical and angiographic outcomes with biodegradable polymer coated sirolimus-eluting stent in de novo coronary artery disease: results of the MANIPAL-FLEX study
Clinical outcomes and complications of treatment with Supraflex stent in patients with coronary artery disease: One-year follow-up
Comparison of clinical outcomes following single versus multivessel percutaneous coronary intervention using biodegradable polymer coated sirolimus-eluting stent in an all-comers patient population
Three-year outcomes of biodegradable polymer-coated ultra-thin (60 µm) sirolimus-eluting stents in real-world clinical practice
Comparison of neointimal coverage between ultrathin biodegradable polymer-coated sirolimus-eluting stents and durable polymer-coated everolimus-eluting stents: Six-month OCT follow-up from the TAXCO study.
Early vascular responses after ultrathin strut biodegradable polymer-coated sirolimus-eluting stent implantation: SiBi OCT study
Preliminary clinical outcomes after implantation of newer-generation biodegradable polymer-coated everolimus-eluting stent in “real-world” patients with coronary artery disease.
Comparison of biodegradable polymer (Everoflex) vs. permanent polymer (Xience Pro) coated everolimus-eluting coronary stent systems in all-comer patient population at a tertiary care hospital - One-year outcome study.
Safety and efficacy of ultra-thin biodegradable polymer-coated everolimus-eluting stent in real-world patients with coronary artery disease – One-year outcomes of Indian multi-centric ‘EVERsafe’ Study.
Safety and efficacy of a novel everolimus-eluting stent system in “real-world” patients with coronary artery disease: A report of preliminary outcomes.
First experience after implantation of ultrathin-strut biodegradable polymer-coated long (44/48 mm) everolimus-eluting stents for treatment of long atherosclerotic lesions in real-world scenario.
Safety and clinical performance of biodegradable polymer-coated ultrathin everolimus-eluting stents in "real-world" patients: A multicentre registry (PERFORM-EVER).
Twelve-month comparative analysis of clinical outcomes using biodegradable polymer-coated everolimus-eluting stents versus durable polymer-coated everolimus-eluting stents in all-comer patients
Evaluation of vascular response and healing after implantation of Tetrilimus everolimus-eluting coronary stent by optical coherence tomography (EVER-OCT): 3 and 6 month serial analysis
Clinical experience after implantation of ultrathin strut biodegradable polymer-coated everolimus-eluting stents for treatment of atherosclerotic lesions: all-comer single-centre registry with a subgroup analysis of patients with ultra-long stents
Twelve months clinical outcomes after percutaneous coronary intervention with bare metal stents in unselected real-life patients with coronary artery disease: Results from FLEXUS Study.
Analysis of 12 months clinical outcomes associated with implantation of ultrathin (60 μm) bare metal stent in an unselected real-world population with coronary artery disease.
Evaluation of prolonged safety and efficacy of biodegradable polymer coated sirolimus-eluting coronary stent system: 1-year outcomes of the INDOLIMUS Registry
Comparison of two biodegradable polymer coated, drug-eluting coronary stents paclitaxel vs. sirolimus, with 6-years clinical follow-up: BIOPRESS (BIOdegradable Polymer REgistry Smt Stents) Infinnium vs. Supralimus
Systemic exposure of sirolimus after coronary stent implantation in patients with de novo coronary lesions: Supralimus-Core® pharmacokinetic study.
Favorable Outcomes after Implantation of Biodegradable Polymer Coated Sirolimus-Eluting Stents in Diabetic Population: Results from INDOLIMUS-G Diabetic Registry
Seven-year clinical outcomes in patients undergoing percutaneous coronary intervention with biodegradable polymer coated sirolimus-eluting stent: Results from a single-center real-world experience
In vivo assessment of stent recoil of biodegradable polymer- coated cobalt- chromium sirolimus-eluting coronary stent system.
Clinical outcomes from unselected “real-world” patients with long coronary lesion receiving 40 mm biodegradable polymer coated sirolimus-eluting stent
Clinical performance of the cobalt-chromium biodegradable polymer coated sirolimus-eluting stent in an unselected real-world population
Clinical performance of biodegradable polymer coated Sirolimus-eluting stent in multivessel disease: Results from MULTIDES study
Evaluation of clinical outcomes in patients undergoing dual vessel percutaneous coronary intervention using sirolimus-eluting coronary stent system in India
Clinical outcomes of successful sirolimus-eluting stent implantation in patients with chronic total occlusion in the real clinical practice
Clinical performance of biodegradable polymer-coated sirolimus-eluting stents in unselected real-world population with coronary artery disease: results from the multicenter CORE Registry
Biodegradable-polymer-based, sirolimus-eluting Supralimus stent: 6-month angiographic and 30-month clinical follow-up results from the series I prospective study
Safety and efficacy of ultra-thin, biodegradable polymer coated sirolimus-eluting Supralimus-core stents in real-world patients: outcomes at 24-month follow-up
Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-year results of the PAINT trial
The real world experience of the biodegradable polymer-coated sirolimus-eluting coronary stent system: results from an "all-comers" clinical experience
Late clinical outcomes after implantation of drug-eluting stents coated with biodegradable polymers: 3-year follow-up of the PAINT randomized trial
Safety and efficacy of sirolimus-eluting stent in diabetic patients compared with non-diabetic patients undergoing percutaneous coronary intervention
Very late outcomes of drug-eluting stents coated with biodegradable polymers: insights from the 5-year follow-up of the randomized PAINT trial
Clinical outcomes from unselected “real-world” patients with long coronary lesion receiving 40 mm biodegradable polymer coated sirolimus-eluting stent
Use of Supralimus drug eluting stent with sirolimus and absorbable polymer in the treatment of acute coronary syndrome patients undergoing percutaneous coronary intervention: E- SERIES Registry
A first-in-man study of sirolimus-eluting, biodegradable polymer coated cobalt chromium stent in real life patients.
Nine-months clinical outcome of biodegradable polymer coated sirolimus-eluting stent system: a multi-centre “real-world” experience
Experience with biodegradable polymer coated sirolimus-eluting coronary stent system in “real-life” percutaneous coronary intervention: 24-month data from the Manipal-S Registry
Early vascular healing with biodegradable polymer coated sirolimus-eluting coronary stent implantation: assessed by optical coherence tomography results at 4-month follow-up.